1.
Den Hollander D, Van der Graaf WTA, Desar IME, Le Cesne A. Predictive factors for toxicity and survival of second-line sunitinib in advanced gastrointestinal stromal tumours (GIST). AO [Internet]. 2019 Nov. 2 [cited 2026 May 17];58(11):1648-54. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24741